argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – 7:30am ET Amsterdam, the Netherlands— argenx SE (Euronext ...
Billionaire investor Bill Ackman vows to abandon Amsterdam stock exchange over city’s failure ‘to protect tourists’ as antisemitic violence erupts
Ackman said he would moving Pershing Square's secondary shares to London and called on Universal Music Group to switch to New York.
Le Lézard23m
Spectra7 Announces Omar Javaid as the New CEO
Zai Lab Limited and argenx (Euronext & Nasdaq: ARGX) today announced that China's National Medical Products Administration (NMPA) approved the supplemental Biologics License Application (sBLA) for ...
Business Wire13m
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & Nasdaq: ARGX) today announced that China’s National Medical Products Administrat ...